A COMPREHENSIVE REVIEW ON MUCORMYCOSIS IN COVID-19 PATIENTS IN INDIA
Sanjana Singh, Sanjita Das*
ABSTRACT
In the present scenario of COVID-19 pandemic and the second wave of COVID-19 spread in India, nearly 9,000 peoples are infected with black fungus or Mucormycetes in India and 200 patients lost their lives. Mucormycosis is a fungal infection is caused by the Mucomycetes found in soil and organic materials. Though it is not contagious, it is present in atmosphere. It has been observed that the reduced immunity due to COVID-19 infection and excess use of steroids in the treatment of COVID -19 are the main reason of causing black fungus and so it infects the diabetic patients. Mucormycosis is serious infection treat with the help of medication or by the removal of infected tissue by doing surgery. It is considered as a dangerous infection as it spreads throughout body at high-speed causing serious damages like fever, redness around the eyes, nose etc. If it is left untreated, the infection can spread to the lungs or the brain. This can cause: a brain infection, paralysis, pneumonia, seizures, death. The infection Though there are different scopes of its management like Amphotericin B, etc. better treatment medications are yet to be revised in a systematic research. In the present article a detailed highlight on the occurrence of black fungus and its pathophysiology has been elaborated along with its management prospects.
Keywords: COVID- 19, black fungus, Mucormycosis, diabetes, Amphotericin B.
[Full Text Article]
[Download Certificate]
Impact Factor : 8.181 
